Logo
D

Disc Medicine

97 employees

Disc Medicine is a biopharmaceutical company dedicated to transforming the lives of patients with hematologic disorders. We are building a unique portfolio of innovative, first-in-class therapeutic candidates that affect fundamental pathways of red blood cell biology.

Investor insights

Funding rounds participated in

$226M sweet spot round size

Investor type

Public Company

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Funding rounds raised

Total raised

$226M

from investors over 1 rounds

D

Disc Medicine raised $226M on February 22, 2025

FAQ